Skip to main content

Table 9 Change in HbA1c values (with HbA1c denoted in mmol/mol) after dapagliflozin titration

From: The effect of oral diabetes medications on glycated haemoglobin (HbA1c) in Asians in primary care: a retrospective cohort real-world data study

Dapagliflozin dose after titration

0

2.5

5

10

 

-9(-11, -6)#m=67

-9(-10, -8)#m=570

-11(-11, -10)#m=722

  

-1(-4, 2)#m=39

 

3(1, 7)#m=85

  

-3(-4, -2)#m=264

7(3, 9)#m=96

 

1(-1, 3)#m=76

 
  1. Change in HbA1c values after dapagliflozin initiation, titration, or discontinuation. The values above the diagonal represent the instances where the medication has been initiated or up-titrated, while the values below the diagonal represent instances where the medication has been down-titrated or discontinued. The values refer to the mean difference in HbA1c (MD) and 95% confidence intervals. MD below 0 indicate a lowering in HbA1c while those above 0 indicate an increase in HbA1c. #m refers to the number of HbA1c pairs for that dose titration